Press release

[PRESS RELEASE] OurCrowd expands Abu Dhabi investment operations and launches global AI hub, in partnership with ADIO’s Innovation Programme

Abu Dhabi, UAE – 16 November 2022: OurCrowd, Israel’s most active venture firm, is to significantly expand its Abu Dhabi operations with a new venture capital (VC) office and Artificial Intelligence (AI) tech hub enabled by the Abu Dhabi Investment Office (ADIO). The two new initiatives, which were announced during Abu Dhabi Finance Week, will see OurCrowd expand its team based at Abu Dhabi Global Market (ADGM) to 60 over the next four years, as part of a USD 60 million investment by the company in the emirate.  Read more...

Read More

[PRESS RELEASE] OurCrowd to Celebrate $2 Billion Commitments Landmark at 10th Anniversary OurCrowd Global Investor Summit on February 15, 2023 in Jerusalem

Jerusalem, November 9, 2022 – OurCrowd, the leading global venture investing platform and Israel’s most active venture investor, will host its 10th anniversary celebration at the OurCrowd Global Investor Summit on February 15, 2023, in Jerusalem, Israel. The Summit will be held as OurCrowd’s total amount of investment commitments crosses the $2 billion mark. The 2020 Summit, OurCrowd’s last mega conference, was the largest investor event in the Middle East, and one of the biggest business events in Israel’s history.  Read more...

Read More

[PRESS RELEASE] OurCrowd launches $200 million Global Health Equity Fund in collaboration with the WHO Foundation at the Clinton Global Initiative

New York – September 19, 2022 – OurCrowd, a leading global venture firm, announced today the launch of a Global Health Equity Fund (GHEF) in collaboration with the WHO Foundation. The news was shared at the first major Clinton Global Initiative meeting convened since 2016, held in New York City alongside the meeting of the United Nations General Assembly (UNGA). Read more...

Read More

[PRESS RELEASE] Newly Published Phase 3 Study in People with COVID-19 Shows SaNOtize Nitric Oxide Nasal Spray Reduced Viral Load by 99% within Two Days

VANCOUVER, British Columbia & MUMBAI, July 13, 2022–SaNOtize Research & Development Corp., (“SaNOtize”), a Canadian anti-infective-focused therapeutics company, and Glenmark Pharmaceuticals Limited (“Glenmark”), a global, innovation-driven pharmaceutical company, today published results of a Phase 3 clinical trial in The Lancet Regional Health Southeast Asia, illustrating the effectiveness of nitric oxide nasal spray (NONS™) for the treatment of adult patients with COVID-19. Read more...

Read More

[PRESS RELEASE] OurCrowd First Israeli Company to Partner With the Singapore Economic Development Board in the Global Innovation Alliance (GIA) Programme

JERUSALEM & SINGAPORE–(BUSINESS WIRE)–OurCrowd, Israel’s most active venture firm, today announced its partnership with the Singapore Economic Development Board (EDB), under its Global Innovation Alliance (GIA) programme. The GIA is a platform that serves to catalyze cross-border collaboration between Singapore and major innovation hubs globally. Read more...

Read More

Latest from Twitter